Clinical Trials Directory

Trials / Unknown

UnknownNCT02604927

Beta-alanine Supplementation and Its Effects on Performance, Muscle Carnosine Content and Safety in Athletes With Spinal-cord Injury

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Sao Paulo · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Paralympians competing in wheelchair sports may experience a very high glycolytic demand (and therefore acidotic environment) in their upper-body muscles, particularly in high-intensity disciplines. Previous studies from our group have shown that upper-body exercise is very sensitive to the ergogenic effects of β-alanine supplementation and to other nutritional supplements capable of increasing buffering capacity. In line with this, have shown that upper-body muscle groups benefit more from artificially induced alkalosis than lower-body muscle groups. Although β-alanine appears to be an interesting and potential ergogenic supplement for paralympians, no study to date has assessed its potential in wheelchair athletes.In this study, we will evaluate the effects of β-alanine supplementation on upper-body performance in wheelchair athletes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBeta-alanine
DIETARY_SUPPLEMENTDextrose

Timeline

Start date
2016-02-01
Primary completion
2016-11-01
Completion
2017-09-01
First posted
2015-11-16
Last updated
2015-11-16

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02604927. Inclusion in this directory is not an endorsement.